KYPROLIS
Dead / Abandoned — Abandoned — incomplete response (as of 22 May 2017)
What this means for you
This application is over — abandoned 26 Apr 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85675722
- Mark type
- Design + words
- Filed
- 12 Jul 2012
- Published for opposition
- 02 Jul 2013
- Abandoned
- 26 Apr 2017
- Attorney of record
- Richard M. LaBarge
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological diseases and disorders
Owner
- Onyx Pharmaceuticals, Inc., Thousand Oaks, CA, US
- Onyx Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 22 May 2017 — ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
- 22 May 2017 — ABANDONMENT - INCOMPLETE RESPONSE
- 01 May 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 May 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Apr 2017 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 25 Oct 2016 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 25 Oct 2016 — FINAL REFUSAL E-MAILED
- 25 Oct 2016 — SU - FINAL REFUSAL - WRITTEN
- 10 Oct 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Oct 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Oct 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Oct 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Oct 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Sept 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Sept 2016 — NON-FINAL ACTION E-MAILED